- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/19 - Particulate form, e.g. powders lyophilised
Patent holdings for IPC class A61K 9/19
Total number of patents in this class: 4217
10-year publication summary
252
|
287
|
367
|
389
|
484
|
496
|
463
|
465
|
409
|
113
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2961 |
55 |
Amgen Inc. | 3779 |
48 |
CJ BioScience, Inc. | 82 |
38 |
Novartis AG | 11238 |
36 |
Regeneron Pharmaceuticals, Inc. | 3650 |
36 |
Merck Patent GmbH | 5909 |
34 |
Pfizer Inc. | 3322 |
28 |
Mayo Foundation for Medical Education and Research | 2981 |
28 |
Otsuka Pharmaceutical Co., Ltd. | 1426 |
25 |
Board of Regents, The University of Texas System | 5370 |
24 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
24 |
Catalent U.K. Swindon Zydis Limited | 46 |
23 |
Allergan, Inc. | 2600 |
22 |
Merck Sharp & Dohme LLC | 3689 |
22 |
Genentech, Inc. | 3742 |
21 |
Ferring B.V. | 705 |
20 |
BioNTech SE | 482 |
18 |
Baxter International Inc. | 2425 |
17 |
Nitto Denko Corporation | 7879 |
16 |
Baxter Healthcare S.A. | 1810 |
16 |
Other owners | 3666 |